Impax Laboratories, Inc. (IPXL) Financial Analysis & Valuation | Quarter Chart
Impax Laboratories, Inc. (IPXL)
IPXLPrice: $18.3
Fair Value: 🔒
🔒score
A technology-based specialty pharmaceutical company focused on the development, manufacturing, and commercialization of controlled drug delivery systems, generic formulations, and branded pharmaceutical products across two main segments: Impax Generics and Impax Specialty Pharma
A technology-based specialty pharmaceutical company focused on the development, manufacturing, and c... more
Description
Shares
| Market Cap | $0 | Exchange | NASDAQ |
| Sector | Healthcare | Industry | Medical - Pharmaceuticals |
| Country | US | CEO | — |
| IPO Date | 1995-12-19 | CAGR | — |
| Employees | — | Website | www.impaxlabs.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | — | Total Yield | — |
IPXL chart loading...
Fundamentals
Technicals
| Enterprise Value | $2.09B | P/E Ratio | — |
| Forward P/E | — | PEG Ratio | — |
| P/S Ratio | — | P/B Ratio | 7.02 |
| P/CF Ratio | 17.63 | P/FCF Ratio | — |
| EPS | — | EPS Growth 1Y | — |
| EPS Growth 3Y | — | EPS Growth 5Y | — |
| Revenue Growth 1Y | -6.33% | Gross Margin | 0.31% |
| Operating Margin | -0.52% | Profit Margin | -0.6% |
| ROE | -1.16% | ROA | -0.35% |
| ROCE | -0.4% | Current Ratio | 1.96 |
| Quick Ratio | 1.52 | Cash Ratio | 0.51 |
| Debt/Equity | 4.21 | Interest Coverage | -7.54 |
| Altman Z Score | — | Piotroski Score | — |